Shukra Pharmaceuticals Q4 Results

  • BSE: 524632
  • NSE: -
  • ISIN: INE551C01044
  • Sector: Biotechnology & Drugs
BSE
51.082.41 (4.95%)
Volume2.84 L
Updated: Wed 14 Jan, 2026 | 15:50:15
NSE
This stock is not traded on NSE
Today: 48.59
51.10
52-Wk: 11.74
65.26

Q4 Results Highlights

Quarter ended Mar 25

    Note: Comparison is on QoQ basis

    Quarterly - Shukra Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 25Dec 24QoQ CompMar 24YoY Comp
    Total Operating Expense 6.897.34-6.13%6.97-1.05%
    Depreciation/ Amortization 0.940.7035.27%0.5282.43%
    Operating Income 6.383.2496.79%3.9262.78%
    Net Income 5.393.1670.23%3.9935.14%
    Other Operating Expenses Total 2.441.14113.00%3.25-24.90%
    Net Income Before Taxes 7.574.0984.87%5.2244.92%
    Total Revenue 13.2710.5825.37%10.8821.92%
    Selling/ General/ Admin Expenses Total 1.751.5513.05%1.5810.77%
    Diluted Normalized EPS 0.120.0769.04%0.0933.63%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market